Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000179315 | SCV000331954 | benign | not specified | 2015-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001698994 | SCV000523690 | likely benign | not provided | 2020-10-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000541038 | SCV000650282 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000179315 | SCV001879986 | benign | not specified | 2024-08-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000179315 | SCV002071460 | likely benign | not specified | 2019-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001698994 | SCV004156400 | likely benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | PLEC: BP4, BP7, BS2 |
Diagnostic Laboratory, |
RCV000179315 | SCV001744495 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001698994 | SCV001927078 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001698994 | SCV001972068 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537485 | SCV004741703 | benign | PLEC-related disorder | 2021-11-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |